Multivariate meta-analysis of controlled drug studies for obsessive-compulsive disorder

Journal of Clinical Psychopharmacology

Volumn 22, Issue 3, 2002, Pages 309-317

  Ackerman, Deborah L ^a   Greenland, Sander ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLOMIPRAMINE; FLUVOXAMINE; PAROXETINE; SERTRALINE;

ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DISEASE COURSE; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; HUMAN; META ANALYSIS; MULTIVARIATE ANALYSIS; OBSESSION; ONSET AGE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

CLOMIPRAMINE; HUMANS; MULTIVARIATE ANALYSIS; OBSESSIVE-COMPULSIVE DISORDER; PLACEBO EFFECT; RANDOMIZED CONTROLLED TRIALS; SEROTONIN UPTAKE INHIBITORS; SINGLE-BLIND METHOD;

EID: 0036109031     PISSN: 02710749     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004714-200206000-00012     Document Type: Article

References (41)

1. Clomipramine, fluoxetine, and behavior therapy in the treatment of obsessive-compulsive disorder: A meta-analysis
2. Efficacy of drug treatment in obsessive-compulsive disorder: A meta-analytic review
3. Meta-analysis of pharmacotherapy trials for obsessive-compulsive disorder
4. Efficacy and tolerability of serotonin transport inhibitors in obsessive compulsive disorder: A meta-analysis
5. Effectiveness of psychological and pharmacological treatments for obsessive-compulsive disorder: A quantitative review
6. Behavioral versus pharmacological treatments of obsessive compulsive disorder: A meta-analysis
7. A review of the efficacy of selective serotonin reuptake inhibitors in obsessive-compulsive disorder
8. Predictors of treatment response in obsessive compulsive disorder: Multivariate analyses from a multicenter trial of clomipramine
9. Clinical characteristics of responders to fluoxetine treatment of OCD
10. Meta-analysis
11. Clomipramine in the treatment of patients with obsessive-compulsive disorder
12. Obsessive-compulsive disorder: A double-blind, placebo-controlled trial of clomipramine in 27 patients
13. Clomipramine and obsessive compulsive disorder: A placebo-controlled double-blind study of 32 patients
14. Clomipramine in obsessive-compulsive disorder: Clinical response and plasma levels
15. Symptoms and physiologic manifestations in obsessive compulsive patients before and after treatment with clomipramine
16. Paroxetine versus clomipramine in the treatment of obsessive-compulsive disorder
17. Efficacy of fluvoxamine in obsessive-compulsive disorder: A double-blind comparison with placebo
18. A controlled trial of fluvoxamine in obsessive-compulsive disorder: Implications for a serotonergic theory
19. Short- and long-term treatment of obsessive-compulsive disorder with fluvoxamine
20. Treatment of obsessive-compulsive disorder with fluvoxamine: A multicentre, double-blind, placebo-controlled trial
21. A double-blind, placebo-controlled study of fluoxetine in patients with DSM-III-R obsessive-compulsive disorder
22. A multicenter investigation of fixed-dose fluoxetine in the treatment of obsessive-compulsive disorder
23. Placebo-controlled trial of fluoxetine and phenelzine for obsessive-compulsive disorder
24. Results of a double-blind placebo controlled trial of a new serotonin uptake inhibitor, sertraline, in the treatment of obsessive-compulsive disorder
25. Sertraline in obsessive-compulsive disorder: A double-blind comparison with placebo
26. Double-blind parallel comparison of three dosages of sertraline and placebo in outpatients with obsessive-compulsive disorder
27. Placebo-controlled, multicenter study of sertraline treatment for obsessive-compulsive disorder
28. A double-blind, placebo controlled study of trazodone in patients with obsessive-compulsive disorder
29. Fluvoxamine vs. clomipramine treatment in obsessive-compulsive disorder: A preliminary study
30. Fluvoxamine versus clomipramine in the treatment of obsessive compulsive disorder: A multicenter, randomized, double-blind, parallel group comparison
31. Fluvoxamine versus clomipramine for obsessive-compulsive disorder: A double-blind comparison
32. A double-blind study of fluvoxamine and clomipramine in the treatment of obsessive-compulsive disorder
33. Double-blind comparison of fluoxetine versus clomipramine in the treatment of obsessive compulsive disorder
34. Specificity of serotonin reuptake inhibitors in the treatment of obsessive-compulsive disorder: Comparison of fluvoxamine and desipramine
35. Multicenter double-blind comparison of sertraline and desipramine for concurrent obsessive-compulsive and major depressive disorders
36. Relationship between early side effects and therapeutic effects of clomipramine therapy in OCD
37. Side effects as predictors of drug response in OCD
38. Risk factors for the development of placebo adverse reactions in a multicenter clinical trial
39. Fluvoxamine in the treatment of obsessive-compulsive disorder and related conditions
40. Clomipramine and exposure for obsessive-compulsive rituals, I
41. Treatment of obsessive-compulsive disorder: The Expert Consensus Panel for obsessive-compulsive disorder